Similarly, global loss of Ptger2 alone had no effect on STZ-induced hyperglycemia, but wild-type mice treated with a combination of an EP2 agonist and EP4 agonist were protected against STZ-induced hyperglycemia compared to the controls [33]. The gene discussed is PTGER2; the disease is Hyperglycemia.